BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1604576)

  • 1. The interaction of gamma irradiation of the allograft and recipient administration of cyclosporine in rat small bowel transplantation.
    Foster PF; Sankary HN; Kociss K; Xiao F; Williams JW
    Transplant Proc; 1992 Jun; 24(3):1175-6. PubMed ID: 1604576
    [No Abstract]   [Full Text] [Related]  

  • 2. Small bowel transplantation in the rat: the effect of donor-specific transfusion 24 hours pretransplant and cyclosporine.
    Fecteau A; Tchervenkov J; Guttman FM; Rosenmann E
    Transplant Proc; 1992 Jun; 24(3):1166. PubMed ID: 1604571
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of donor irradiation to prolong allograft survival in small bowel transplantation in rats.
    Lee TK; Langrehr JM; Moynihan HL; Stangl MJ; Lee KK; Schraut WH
    Transplant Proc; 1992 Jun; 24(3):1183-4. PubMed ID: 1604579
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of spleen transplantation and cyclosporine A treatment to ameliorate survival after small bowel transplantation.
    Pirenne J; D'Silva M; Jacquet N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1206. PubMed ID: 8442087
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
    Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
    Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
    [No Abstract]   [Full Text] [Related]  

  • 6. Allograft ultraviolet-B irradiation in rat small intestinal transplantation.
    Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1624-5. PubMed ID: 8030062
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-VLA-4 and cyclosporine synergistically prolong rat heterotopic small bowel allografts.
    Tice DG; Bruch D; Ikramuddin S
    Transplant Proc; 1996 Oct; 28(5):2496. PubMed ID: 8907920
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of short-term immunosuppressive therapy with FK 506 or CyA on the donor in small intestine allotransplantation in rats.
    Santiago SF; Fukuzawa M; Azuma T; Okada A
    Transplant Proc; 1992 Jun; 24(3):1189. PubMed ID: 1376520
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of ultraviolet B-irradiated leukocyte transfusions in intestinal transplantation.
    Xiao F; Foster PF; Sankary HN; Kociss K; Templeton AC; Williams JW
    Transplant Proc; 1992 Jun; 24(3):1167-8. PubMed ID: 1604572
    [No Abstract]   [Full Text] [Related]  

  • 10. Indefinite small bowel allograft survival after limited immunosuppressive therapy is not due to specific hyporesponsiveness.
    Langrehr JM; Hoffman RA; Müller AR; Lee KK; Demetris AJ; Schraut WH
    Transplant Proc; 1991 Dec; 23(6):3248-50. PubMed ID: 1721425
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of long-term small bowel graft survival by low-dose immunosuppression in tolerized recipient rats.
    Chen H; Xu D; Qi S; Busque S; Tan A; Daloze P
    Transplant Proc; 1997; 29(1-2):697-8. PubMed ID: 9123486
    [No Abstract]   [Full Text] [Related]  

  • 12. Priming the recipient abrogates the inhibitory effect of cyclosporine on specific sIgA production against cholera toxin in small bowel transplantation.
    Xia W; Kirkman RL
    Transplant Proc; 1992 Jun; 24(3):1139-40. PubMed ID: 1604557
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation.
    He G; Wang M; Xu H; Tian L; Yu J; Stepkowski SM; Kahan BD
    Transplant Proc; 1996 Oct; 28(5):2469. PubMed ID: 8907906
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytoimmunologic monitoring of small bowel allograft recipients.
    Graeb C; Stangl MJ; Mebert H; Fischer T; Hammer C
    Transplant Proc; 1992 Jun; 24(3):1153-4. PubMed ID: 1376515
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural killer activity is down-regulated following allogeneic small bowel transplantation.
    Tice DG
    Transplant Proc; 1992 Jun; 24(3):1135-6. PubMed ID: 1604554
    [No Abstract]   [Full Text] [Related]  

  • 16. Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts.
    Langrehr JM; Markus PM; Lee TK; Müller AR; Banner B; Lee KK; Schraut WH
    Transplant Proc; 1992 Jun; 24(3):1138. PubMed ID: 1604556
    [No Abstract]   [Full Text] [Related]  

  • 17. Pretreatment with irradiation and donor-specific transfusion prolongs survival in small intestinal transplantation.
    Greenstein SM; Sun SC; Senitzer D; Schechner RS; Tellis VA
    Transplant Proc; 1993 Feb; 25(1 Pt 1):490-1. PubMed ID: 8438391
    [No Abstract]   [Full Text] [Related]  

  • 18. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
    Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
    Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS
    Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
    Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
    Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.